An alternative mechanism for the differential involvement of IRS-1 and IRS-2 in cancer that would allow for the activation of a common signaling pathway by these adaptor proteins was revealed during the analysis of Irs1-/- mammary tumors. This evidence concerns the gene IRS1 and breast cancer.